| The Task Force has received donations from many [[pharmaceutical companies]] and other notable entities, including [[pharmaceutical_companies:Abbott]], [[pharmaceutical_companies:AbbVie]], [[American Endowment Foundation]], [[pharmaceutical_companies:Bayer]], the [[Bill & Melinda Gates Foundation]], [[BioScience]], [[Bruyere Research Institute]], [[Center for Compassionate Leadership]], [[center for disease control and prevention|U.S. Centers for Disease Control and Prevention]] (CDC), the [[CDC Foundation]], the [[Coalition for Epidemic Preparedness Innovations]] (CEPI), [[Conrad N. Hilton Foundation]], [[medical_technology_companies:Dexcom]], [[Eagle Medical Services]], [[pharmaceutical_companies:Eisai]], [[Emory University]], [[pharmamceutical_companies:Genentech]], [[pharmaceutical_companies:Gilead Sciences]], [[pharmaceutical_companies:GlaxoSmithKline]], [[Hewlett Packard]], [[Hiroshima University]], [[International Federation of Pharmaceutic Manufacturers & Associations]] (IFPMA), [[Izumi Foundation]], [[pharmaceutical_companies:Johnson & Johnson]], [[Medical Bridges]], [[MedShare]], [[MedWish]], [[pharmaceutical_companies:Merck]], [[National Association of Chronic Disease Directors]], [[National Health Institute]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], [[Robert Wood Johnson Foundation]], [[pharmaceutical_companies:Roche]], [[Sanofi Espoir Foundation]], [[Scripps]], [[pharmaceutical_companies:Seqirus]], [[medical_technology_companies:Siemens Healthcare]], [[Stanford University]], [[Supplies Over Seas]], [[Templeton World Charity Foundation]], U.K. Foreign Commonwealth & Development Office ([[UK Aid]]), U.S. Agency for International Development ([[USAID]]), [[U.S. Department of State]], U.S. [[National Institutes of Health]] (NIH), [[United Nations Children’s Fund]], [[Wellcome Trust]], and the [[World Health Organization]] (WHO). | The Task Force has received donations from many [[pharmaceutical companies]] and other notable entities, including [[pharmaceutical_companies:Abbott]], [[pharmaceutical_companies:AbbVie]], [[American Endowment Foundation]], [[pharmaceutical_companies:Bayer]], the [[Bill & Melinda Gates Foundation]], [[BioScience]], [[Bruyere Research Institute]], [[Catholic Health Association]], [[Center for Compassionate Leadership]], [[Centers for Disease Control and Prevention]] (CDC), the [[CDC Foundation]], [[Center for Global Health Innovation]], the [[Coalition for Epidemic Preparedness Innovations]] (CEPI), [[Conrad N. Hilton Foundation]], [[medical_technology_companies:Dexcom]], [[Eagle Medical Services]], [[pharmaceutical_companies:Eisai]], [[Emory University]], [[pharmamceutical_companies:Genentech]], [[pharmaceutical_companies:Gilead Sciences]], [[pharmaceutical_companies:GlaxoSmithKline]], [[Hewlett Packard]], [[Hiroshima University]], [[International Federation of Pharmaceutical Manufacturers & Associations]] (IFPMA), [[Izumi Foundation]], [[pharmaceutical_companies:Johnson & Johnson]], [[Medical Bridges]], [[MedShare]], [[MedWish]], [[pharmaceutical_companies:Merck]], [[National Association of Chronic Disease Directors]], [[National Health Institute]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], [[Robert Wood Johnson Foundation]], [[pharmaceutical_companies:Roche]], [[Sanofi Espoir Foundation]], [[Scripps]], [[pharmaceutical_companies:Seqirus]], [[medical_technology_companies:Siemens Healthcare]], [[Stanford University]], [[Supplies Over Seas]], [[Templeton World Charity Foundation]], U.K. Foreign Commonwealth & Development Office ([[UK Aid]]), U.S. Agency for International Development ([[USAID]]), [[U.S. Department of State]], U.S. [[National Institutes of Health]] (NIH), [[United Nations Children’s Fund]], [[Wellcome Trust]], and the [[World Health Organization]] (WHO).((//Annual Report 2021.// The Task Force for Global Health. Retrieved April 20, 2022, from https://web.archive.org/web/20220215172458/https://www.taskforce.org/annual-report-2021/#section_2)) |
